1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
DaVita Inc.

DaVita Inc.

DVA
DaVita Inc.US flagNew York Stock Exchange
181.66
USD
+2.27
- -
11.66BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
56.04
60.27
47.12
53.1
57.66
66.78
74.35
96.42
110.41
124.85
133.72
150.79
183.8
204.6
Basic EPS, GAAP
3.02
3.41
1.27
4.36
3.52
0.93
5.29
6.46
9.3
6.03
7.62
11.02
10.06
12.38
Free Cash Flow per Basic Share
5.49
3.85
4.01
5.67
5.34
4.59
8.52
10.89
12.25
10.34
16.42
17.26
17.66
23.51
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
20.79
23.98
23.22
23.89
25.7
22.26
16.95
12.59
7.77
7.88
11.89
1.5
-9.5
-11.96
Tangible Book Value per Share
-31.92
-28.33
-29.13
-7.41
-11.15
-19.58
-38.06
-51.87
-66.49
-72.41
-70.47
-92.52
-122.81
-134.23
Basic Weighted Avg Shares
210
212
212
202
189
171
153
120
105
93
91
85
74
68
Sales/Revenue/Turnover
11,764
12,795
9,982
10,707
10,877
11,405
11,388
11,551
11,619
11,610
12,140
12,816
13,643
14,010
Operating Margin (%)
12.4
14
16.25
15.71
14.89
13.07
15.41
14.58
15.24
11.31
13.19
15.25
14.74
14.93
Depreciation Expense
528
591
638
720
777
591
615
630
681
733
745
724
715
710
Net Income, GAAP
633
723
270
880
664
159
811
774
978
560
692
936
747
847
Effective Tax Rate (%)
33.87
34.08
30.14
26.6
23.14
24.65
23.39
23.81
20.2
20.5
18.7
18.27
21.76
20.66
Profit Margin (%)
5.38
5.65
2.7
8.22
6.1
1.4
7.12
6.7
8.42
4.83
5.7
7.31
5.47
6.05
Working Capital
1,010
1,548
2,104
1,284
5,703
3,533
1,318
673
769
536
496
773
916
1,334
LT Debt
8,141
8,299
9,001
8,945
9,158
8,173
10,701
10,656
11,402
11,196
10,599
11,386
12,340
12,850
Total Equity
5,303
6,190
5,948
5,823
5,897
5,033
3,500
2,897
2,371
2,225
2,743
2,091
1,158
1,079
Return on Invested Capital (%)
7.33
8.47
7.75
8.35
8.37
7.45
9.01
8.88
9.89
7.31
9.28
11.35
11.1
11.48
Return on Capital (%)
5.93
6.02
2.68
6.87
5.49
2.33
6.31
5.45
6.84
4.39
5.38
7.18
6.16
6.77
Return on Common Equity (%)
15.46
15.06
5.37
18.49
14.21
3.8
27.79
43.99
91.48
76.36
78.21
159.08
- -
113.26

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
535
545
557
LT Borrowings
10,164
10,514
10,664
LT Finance Leases
2,176
2,162
2,186
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
69
66
64
Market Capitalization
7,788
10,172
14,229

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
4,058
4,063
4,190
Cash, Cash Equivalents & STI
701
667
689
Accounts Receivable, Net
2,415
2,459
2,467
Inventories
161
142
152
Total Current Liabilities
3,142
2,867
2,855
Payables & Accruals
1,171
815
777
ST Debt
535
545
557
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.26%
-13.88%
-44.61%
Free Cash Flow
8.32%
3.25%
-10.63%
Net Income, GAAP
55.21%
4.46%
-20.24%
Sales/Revenue/Turnover
3.21%
3.42%
6.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,071
3,187
3,264
3,295
12,816
2025
3,224
3,380
3,420
3,620
13,643
2026
3,416
3,554
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.73
2.56
2.56
3.18
11.02
2025
2.05
2.62
2.09
3.36
10.06
2026
2.93
4.1
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Javier J. Rodriguez
Full Time Employees
78,000
Sector
Healthcare
Industry
Medical - Care Facilities
Address
2000 16th Street Denver CO United States of America 80202
IPO Date
Oct 31, 1995
CIK
0000927066
Website
davita.com
Similar Companies
Gushengtang Holdings Limited (2273.HK)
MD Medical Group Investments Plc (MDMG.L)
Family Care Hospitals Ltd. (FAMILYCARE.BO)
Bangkok Dusit Medical Services Public Company Limited (BDUUF)
Capitol Health Limited (CAJ.AX)
Fresenius SE & Co. KGaA (FRE.DE)
Business
DaVita Inc. DaVita Inc. provides kidney care services, primarily dialysis treatments for patients with chronic kidney failure and end-stage kidney disease; operates approximately 2,675 outpatient dialysis centers in the United States serving more than 200,000 patients and 367 centers in 11 other countries serving around 49,400 patients; offers related laboratory services, including routine tests for dialysis patients and other physician-prescribed tests; delivers home-based hemodialysis, hospital inpatient dialysis, and acute inpatient dialysis services; provides integrated kidney care and disease management through DaVita Integrated Kidney Care for risk-based arrangements; conducts clinical research via DaVita Clinical Research since 1985 across pharmaceutical and medical device development; supports nephrologists with technology solutions through DaVita Physician Solutions; and develops innovative health care solutions for kidney disease patients through DaVita Venture Group. The company, incorporated in 1994 and formerly known as DaVita HealthCare Partners Inc. until a 2016 name change, maintains world headquarters in Denver, Colorado, and generates the majority of revenues from Medicare and government-based programs while targeting commercial payers for higher margins; it holds a 37% share of the U.S. dialysis market and operates internationally across regions including Latin America, Europe, and Asia. DaVita Inc. recently expanded internationally through 2024 acquisitions from Fresenius Medical Care for $300 million, adding over 270 clinics in Brazil, Colombia, Chile, and Ecuador to become Latin America's largest dialysis provider; entered new markets in Ecuador and Chile while deepening presence in Colombia; refinanced debt with a new $1.9 billion Term Loan B-2 and $3.5 billion credit facilities including a $2 billion Term Loan A-2 and $1.5 billion revolving facility in 2025; issued $1 billion in senior notes due 2033; and reported Q3 2025 revenues of $3.42 billion amid volume challenges from flu season, Hurricane Helene, and a cyber incident.

Company News

Company News APIChatGPT

  • zacks.com

    Do Options Traders Know Something About DaVita Stock We Don't?

  • zacks.com

    4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

  • fool.com

    Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express)

  • zacks.com

    DVA & Humana Expand Value-Based Care for Kidney Disease Patients

  • prnewswire.com

    Alebund Pharmaceuticals Announces 2026 Interim Results

  • prnewswire.com

    DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease

  • defenseworld.net

    2,460,987 Shares in DaVita Inc. $DVA Purchased by BlackRock Inc.

  • defenseworld.net

    Bank of New York Mellon Corp Makes New $101.13 Million Investment in DaVita Inc. $DVA

  • defenseworld.net

    Bank of America Corp DE Cuts Holdings in DaVita Inc. $DVA

  • zacks.com

    Is DaVita (DVA) a Great Value Stock Right Now?

  • zacks.com

    DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down

  • schaeffersresearch.com

    Dow Extends Record Run With Over 400-Point Pop

  • zacks.com

    DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth

  • marketbeat.com

    DaVita Q2 Earnings Call Highlights

  • gurufocus.com

    DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic Execution Drive Confidence

  • seekingalpha.com

    DaVita Inc. (DVA) Q2 2026 Earnings Call Transcript

  • reuters.com

    DaVita flags lower revenue per treatment, reaffirms annual forecast

  • zacks.com

    DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates

  • gurufocus.com

    Is DaVita Inc (DVA) Overvalued After Q2 Earnings Beat? EPS at $4.02 and Revenue at $3.554 Billion; GF Score: 86/100

  • prnewswire.com

    DaVita Inc. 2nd Quarter 2026 Results